- STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study findsBy doing hormone therapy upfront in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.STAT · 1mo ago↗ source
- STAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDAASCO, Day 2: promising news around lung cancer, new immunotherapies, and bold words from Rick Pazdur.STAT · 1mo ago↗ source
- STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur saysRick Pazdur on the FDA: “We've had a lot of destruction here, and it doesn't mean that we have to just go back and say, well, let's rebuild it as…STAT